Full video transcriptClick to expand
Auto-generated transcript of @renamalikmd's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00It is really important to follow up
- 0:01when you're on testosterone replacement therapy.
- 0:04Even if you feel great,
- 0:05even if everything feels wonderful,
- 0:06you need to get your blood levels checked on a regular basis.
- 0:10Now what else?
- 0:11Acne and oily skin, some men do experience acne
- 0:14or oily skin while you're taking TRT.
- 0:17Now this is not life threatening, but it can be bothersome.
- 0:19Now some men can also experience breast enlargement
- 0:22or what we call gyne and commastia.
- 0:24Now this can happen because TRT or testosterone specifically
- 0:28gets converted in the blood to estradiol.
- 0:30And estradiol can cause some of this breast enlargement
- 0:34and this may require either changing of doses
- 0:36or addition of other medications.
- 0:38Next up, hair loss.
- 0:40So I've discussed hair loss and testosterone
- 0:41in a prior video, so check that one out.
- 0:44But basically the bottom line is yes,
- 0:46you can develop hair loss, particularly if you are
- 0:49genetically predisposed to losing your hair
- 0:52or male pattern baldness in your family.
- 0:54So testosterone replacement in those cases
- 0:57may expedite hair loss.
TRT monitoring: what follow-up labs actually catch and why
Quick answer
Dr. Malik accurately describes three well-documented side effect pathways of testosterone replacement therapy: androgen-driven sebaceous activity causing acne, aromatase-mediated conversion of testosterone to estradiol contributing to gynecomastia, and DHT-driven acceleration of androgenetic alopecia in genetically predisposed men. Her recommendation for routine bloodwork monitoring aligns with Endocrine Society guidelines, which specify testosterone level checks at 3 and 6 months post-initiation and annually thereafter. The video does not address hematocrit monitoring, which carries clinically significant cardiovascular implications and is a standard component of TRT follow-up panels.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT monitoring: what follow-up labs actually catch and why, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT monitoring: what follow-up labs actually catch and why is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT monitoring: what follow-up labs actually catch and why" from Rena Malik, MD. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Dr.
The reason this review is not generic is the source wording and the canonical claim label "trt trt feeling great still need follow ups acne hair loss and m." In this clip, the useful excerpt is: "It is really important to follow up when you're on testosterone replacement therapy." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Dr.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Dr. Malik accurately describes three well-documented side effect pathways of testosterone replacement therapy: androgen-driven sebaceous activity causing acne, aromatase-mediated conversion of testosterone to estradiol contributing to gynecomastia, and DHT-driven acceleration of androgenetic alopecia in genetically predisposed men. Her recommendation for routine bloodwork monitoring aligns with Endocrine Society guidelines, which specify testosterone level checks at 3 and 6 months post-initiation and annually thereafter. The video does not address hematocrit monitoring, which carries clinically significant cardiovascular implications and is a standard component of TRT follow-up panels.
- Endocrine Society guidelines (Bhasin et al., 2018) recommend testosterone level monitoring at 3 months, 6 months, and annually after TRT initiation, regardless of how you feel.
- Standard TRT monitoring panels include more than just testosterone levels. Hematocrit, PSA, and estradiol are typically measured, and elevated hematocrit can raise clotting risk without producing any noticeable symptoms.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Endocrine Society guidelines (Bhasin et al., 2018) recommend testosterone level monitoring at 3 months, 6 months, and annually after TRT initiation, regardless of how you feel.
- Standard TRT monitoring panels include more than just testosterone levels. Hematocrit, PSA, and estradiol are typically measured, and elevated hematocrit can raise clotting risk without producing any noticeable symptoms.
- Gynecomastia on TRT is driven by aromatase enzyme converting testosterone to estradiol. Not every man aromatizes at the same rate, so this side effect is not universal.
- DHT, not testosterone itself, is the primary driver of male pattern hair loss. TRT raises testosterone, which raises DHT via 5-alpha reductase, which can accelerate genetically programmed follicle miniaturization.
- Acne on TRT is caused by androgen stimulation of sebaceous glands and is documented in dermatology literature. Most cases are manageable, but persistent or severe acne may need dermatology input, not just hormone adjustment.
- If you have a family history of male pattern baldness, discuss this with your prescribing clinician before starting TRT, not after noticing changes.
- The video does not cover all TRT monitoring priorities. Cardiovascular risk factors including lipid panels and hematocrit are part of responsible follow-up care and were not addressed in this clip.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @renamalikmd actually say?
The video makes four main claims: regular blood monitoring is necessary even when you feel fine on TRT; acne and oily skin are real but non-threatening side effects; testosterone converts to estradiol in the blood, which can cause gynecomastia; and hair loss is a genuine risk, especially for men who are genetically predisposed to male pattern baldness.
Dr. Malik frames these as routine side effects worth watching, not emergencies. The tone is practical, not alarmist. She tells viewers that gynecomastia "may require either changing of doses or addition of other medications" and that TRT "may expedite hair loss" rather than cause it from scratch. Those are meaningfully different claims, and the distinction matters.
Does the science back this up?
Mostly yes. The mechanisms described here are well-established, and the monitoring recommendation is consistent with clinical guidelines. Where things get slightly blurry is in the hair loss framing.
On monitoring: the Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) explicitly recommend checking testosterone levels at 3 and 6 months after initiation, then annually. Skipping labs because you feel fine is exactly the kind of mistake those guidelines exist to prevent. Hematocrit, PSA, and lipids are also on that monitoring list, none of which produce symptoms until something has already gone wrong.
On gynecomastia: the testosterone-to-estradiol aromatization pathway is textbook endocrinology. Aromatase enzyme converts testosterone to estradiol, and supraphysiologic or poorly-managed levels can push estrogen high enough to stimulate breast tissue. Rhoden and Morgentaler (2004, New England Journal of Medicine) documented this pathway clearly in their review of TRT risks.
On hair loss: the DHT connection is real. 5-alpha reductase converts testosterone to dihydrotestosterone, and DHT is the primary driver of androgenetic alopecia. Kaufman and Dawber (1999, Journal of Investigative Dermatology) confirmed this mechanism. The word "expedite" is actually the right word here, which is worth noting.
What did they get wrong (or right)?
Credit where it is due: the aromatization explanation is accurate and genuinely useful for patients who have never understood why a testosterone treatment could cause breast changes. Most short-form health content skips the mechanism entirely. She did not.
The hair loss section deserves a small flag, though. Saying "check out my prior video" is not a substitute for explaining the DHT mechanism in this one. A viewer with no prior context might walk away thinking testosterone directly attacks hair follicles, when the actual pathway runs through DHT conversion, a distinction that matters because 5-alpha reductase inhibitors exist as a management option. That omission is not wrong, but it is incomplete.
The acne claim is accurate but thin. Sebaceous gland stimulation by androgens is well-documented (Thiboutot, 2004, Journal of the American Academy of Dermatology), and calling it "not life threatening but bothersome" is fair. She could have mentioned that severe acne cases sometimes require dermatology referral, but that is a missed addition rather than an error.
What should you actually know?
If you are on TRT, the monitoring message here is probably the most important thing in this video. Blood levels alone are not enough. Standard follow-up panels for TRT typically include total and free testosterone, estradiol, hematocrit, PSA, and sometimes a lipid panel. Elevated hematocrit in particular can increase clotting risk and produces zero symptoms until the problem is serious.
Gynecomastia does not happen to everyone, and it is not inevitable. Aromatization rates vary considerably between individuals based on body composition and genetics. If it does occur, the management options Dr. Malik references are real, but those decisions belong in a conversation with a prescribing clinician, not a TikTok comment section.
On hair loss: if male pattern baldness runs in your family and you are considering TRT, this is a conversation worth having before you start, not after you notice thinning. The "genetically predisposed" framing here is accurate. TRT does not give you a gene you did not have. It can, however, accelerate a process that was already written into your biology.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Rena Malik, MD · TikTok creator
29.2K views on this video
TRT: Feeling great? Still need follow-ups! 😉 Acne, hair loss, and more. Let's check those levels regularly! #TRT #Testosterone #MensHealth #HormoneTherapy #HairLoss #renamalikmd
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about endocrine society guidelines (bhasin et al., 2018) recommend testosterone level?
Endocrine Society guidelines (Bhasin et al., 2018) recommend testosterone level monitoring at 3 months, 6 months, and annually after TRT initiation, regardless of how you feel.
What does the video say about standard trt monitoring panels include more than just testosterone levels.?
Standard TRT monitoring panels include more than just testosterone levels. Hematocrit, PSA, and estradiol are typically measured, and elevated hematocrit can raise clotting risk without producing any noticeable symptoms.
What does the video say about gynecomastia on trt?
Gynecomastia on TRT is driven by aromatase enzyme converting testosterone to estradiol. Not every man aromatizes at the same rate, so this side effect is not universal.
What does the video say about dht, not testosterone itself,?
DHT, not testosterone itself, is the primary driver of male pattern hair loss. TRT raises testosterone, which raises DHT via 5-alpha reductase, which can accelerate genetically programmed follicle miniaturization.
What does the video say about acne on trt?
Acne on TRT is caused by androgen stimulation of sebaceous glands and is documented in dermatology literature. Most cases are manageable, but persistent or severe acne may need dermatology input, not just hormone adjustment.
What does the video say about if you have a family history of male pattern baldness,?
If you have a family history of male pattern baldness, discuss this with your prescribing clinician before starting TRT, not after noticing changes.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Rena Malik, MD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.